|
May 14
|
BioMarin Pharmaceutical Inc. (BMRN): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying
|
|
May 12
|
BioMarin Presents New Data for VOXZOGO® (vosoritide) in Children with Achondroplasia and Other Skeletal Conditions at Two International Endocrinology Meetings
|
|
May 10
|
Shareholders Will Be Pleased With The Quality of BioMarin Pharmaceutical's (NASDAQ:BMRN) Earnings
|
|
May 9
|
BioMarin Pharmaceutical Inc. (BMRN): Among Billionaire Paul Singer’s Stock Picks with Huge Upside Potential
|
|
May 9
|
1 Healthcare Stock with Competitive Advantages and 2 to Brush Off
|
|
May 8
|
Q1 Earnings Recap: AbbVie (NYSE:ABBV) Tops Therapeutics Stocks
|
|
May 8
|
Therapeutics Stocks Q1 Results: Benchmarking Sarepta Therapeutics (NASDAQ:SRPT)
|
|
May 7
|
BioMarin Pharmaceutical Inc. (BMRN): Among Stocks That Will Make You Rich In 3 Years
|
|
Mar 26
|
Is BioMarin Pharmaceutical Inc. (BMRN) a Promising Biotech Stock According to Wall Street Analysts
|
|
Mar 24
|
Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks
|
|
Mar 21
|
BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?
|
|
Mar 21
|
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
|
|
Mar 21
|
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)
|
|
Mar 20
|
BioMarin Pharmaceutical (BMRN): Among Paul Singer’s Latest Portfolio’s Top Stock Picks
|
|
Mar 20
|
BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) Annual Cl...
|
|
Mar 20
|
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks
|
|
Mar 19
|
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack
|
|
Mar 12
|
Wall Street Analysts Believe BioMarin (BMRN) Could Rally 36.57%: Here's is How to Trade
|
|
Mar 12
|
Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term
|
|
Mar 11
|
PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study
|